Pravastatin prevents the progression of accelerated coronary artery disease after heart transplantation in a rabbit model
This study was designed to investigate the effects of pravastatin (Pr) on accelerated coronary arteriosclerosis in transplanted hearts. The rabbit hearts were transplanted to the recipients’ neck heterotopically, and received FK506. The rabbits in group 1 were fed a normal diet (ND), and cholesterol-rich diet (CD) in group 2 and 3. Pr (10 mg/kg) was given to group 3. They were sacrificed at 4 weeks and the severity of myocardial rejection and arteriosclerosis was assessed and scored histologically. The serum lipid levels were significantly elevated by a CD. However, addition of Pr had no effect on the levels of LDL and total cholesterol (TC). There was no significant difference in myocardial rejection in each group. Transplanted hearts in group 2 showed more severe arteriosclerotic lesions than those in group 1. Pr treatment in group 3 diminished the severity of coronary arteriosclerosis. Pr may prevent the accelerated coronary arteriosclerosis after heart transplantation without significant changes in TC and LDL.
Key wordsHeart transplantation Coronary arteriosclerosis Pravastatin FK506
Unable to display preview. Download preview PDF.
- 4.Carrel A (1907) The surgery of blood vessels, etc. Bull Johns Hobkins Hosp 18: 18Google Scholar
- 6.Eich D, Thompson JA, Ko D, Hatillo A, 10. Lower R, Katz S, Katz M, Hess ML (1991) Hypercholesterolemia in long term survivors of heart transplantation. An early marker of accelerated coronary artery disease. J Heart Lung Transplant 10: 45–49Google Scholar
- 7.Gao SZ, Schroeder JS, Alderman EL, 11. Hunt SA, Silverman JF, Wiederhold V, Stinson EB (1987) Clinical laboratory correlates of accelerated coronary ar- 12. tery disease in the cardiac transplant patient. Circulation 76: 56–61Google Scholar
- 11.Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Science 362: 801–809Google Scholar